cfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma

doi:10.21037/tlcr-20-442

	cfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma
	He, Qiong 1,4,5; Zhu, Xian 3; Shi, Xun 1,4,5; Lin, Chen 1,4,5; Jin, Yin 1,4,5; Yan, Junrong 2; He, Jiachen 2; Yu, Xinmin 1,4,5
刊名	TRANSLATIONAL LUNG CANCER RESEARCH
	2020-06-01
卷号	9
ISSN号	2218-6751
DOI	10.21037/tlcr-20-442
通讯作者	Yu, Xinmin(yuxm@zjcc.org.cn)
WOS关键词	ACQUIRED-RESISTANCE
WOS研究方向	Oncology ; Respiratory System
语种	英语
出版者	AME PUBL CO
WOS记录号	WOS:000547884300040
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/102955]
专题	中国科学院合肥物质科学研究院
通讯作者	Yu, Xinmin
作者单位	1.Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou 310022, Peoples R China 2.Nanjing Geneseeq Technol Inc, Nanjing 210032, Peoples R China 3.Zhejiang Univ, Dept Cardiovasc Surg, Affiliated Hosp 2, Sch Med, Hangzhou 310022, Peoples R China 4.Chinese Acad Sci, Inst Canc & Basic Med ICBM, Hangzhou 310022, Peoples R China 5.Univ Chinese Acad Sci, Canc Hosp, Dept Med Oncol, Hangzhou 310022, Peoples R China
推荐引用方式 GB/T 7714	He, Qiong,Zhu, Xian,Shi, Xun,et al. cfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma[J]. TRANSLATIONAL LUNG CANCER RESEARCH,2020,9.
APA	He, Qiong.,Zhu, Xian.,Shi, Xun.,Lin, Chen.,Jin, Yin.,...&Yu, Xinmin.(2020).cfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma.TRANSLATIONAL LUNG CANCER RESEARCH,9.
MLA	He, Qiong,et al."cfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma".TRANSLATIONAL LUNG CANCER RESEARCH 9(2020).